Liraglutide reduced a composite renal outcome at a median 4 y in patients with type 2 diabetes and high CV risk. [electronic resource]
Producer: 20190523Description: JC66 p. digitalISSN:- 1539-3704
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.